XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Beginning of period (in shares) at Oct. 02, 2021   28,047,000        
Exercise of stock options and vesting of other share-based awards   60,000        
Treasury shares purchased (in shares)   (110,000)        
End of period (in shares) at Jan. 01, 2022   27,997,000        
Beginning of period at Oct. 02, 2021 $ 1,028,232 $ 538 $ 639,778 $ (1,043,091) $ 1,433,991 $ (2,984)
Exercise of stock options and vesting of other share-based awards   1        
Share-based compensation expense     6,270      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (3,394)      
Treasury shares purchased       (10,131)    
Net income 23,423       23,423  
Other comprehensive income (loss) (306)         (306)
End of period at Jan. 01, 2022 $ 1,044,095 $ 539 642,654 (1,053,222) 1,457,414 (3,290)
Beginning of period (in shares) at Oct. 01, 2022 27,679,000 27,679,000        
Exercise of stock options and vesting of other share-based awards   49,000        
Treasury shares purchased (in shares)   (116,000)        
End of period (in shares) at Dec. 31, 2022 27,612,000 27,612,000        
Beginning of period at Oct. 01, 2022 $ 1,095,731 $ 541 652,467 (1,093,483) 1,572,234 (36,028)
Exercise of stock options and vesting of other share-based awards   0        
Share-based compensation expense     5,683      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (4,091)      
Treasury shares purchased       (11,470)    
Net income 42,190       42,190  
Other comprehensive income (loss) 22,216         22,216
End of period at Dec. 31, 2022 $ 1,150,259 $ 541 $ 654,059 $ (1,104,953) $ 1,614,424 $ (13,812)